Beijing Beilu Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001QK9
CNY
9.57
-0.11 (-1.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,197.39
977.26
880.43
754.43
855.00
819.98
812.47
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,197.39
977.26
880.43
754.43
855.00
819.98
812.47
Raw Material Cost
683.90
548.87
503.90
374.98
353.17
304.39
263.83
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
178.57
0.00
0.00
0.00
0.00
109.06
106.19
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
40.15
58.47
53.32
49.32
45.91
6.21
0.13
Selling and Distribution Expenses
334.15
304.94
279.12
269.34
338.06
322.78
313.41
Other Expenses
-13.18
0.32
6.06
4.25
-0.32
-6.80
-5.78
Total Expenditure (Excl Depreciation)
1,104.93
915.44
896.95
736.14
733.94
674.40
625.80
Operating Profit (PBDIT) excl Other Income
92.5
61.8
-16.5
18.3
121.1
145.6
186.70000000000002
Other Income
18.65
20.58
21.14
25.04
39.37
21.61
30.13
Operating Profit (PBDIT)
200.39
171.00
84.17
119.61
216.59
203.24
234.33
Interest
40.15
58.47
53.32
49.32
45.91
6.21
0.13
Exceptional Items
53.46
-12.50
-45.61
6.81
13.23
19.41
174.84
Gross Profit (PBDT)
513.49
428.39
376.53
379.45
501.82
515.59
548.64
Depreciation
102.65
100.05
88.35
80.51
63.91
43.91
21.08
Profit Before Tax
111.05
-0.02
-103.11
-3.41
120.02
172.53
387.95
Tax
19.87
-1.05
-17.95
-10.21
12.06
19.84
54.33
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
92.73
13.65
-71.76
11.28
125.51
174.70
342.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
92.73
13.65
-71.76
11.28
125.51
174.70
342.44
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-4.09
-13.38
-11.44
-15.83
-15.22
-20.71
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
88.65
0.27
-83.20
-4.55
110.29
154.00
342.44
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
0.0
0.0
Reserves
2,258.72
1,667.59
1,650.62
1,776.41
1,857.01
1,741.91
1,450.51
Earnings per share (EPS)
0.18
0.03
-0.15
0.02
0.26
0.36
0.0
Diluted Earnings per share
0.18
0.03
-0.15
0.02
0.26
0.36
0.0
Operating Profit Margin (Excl OI)
6.6%
5.15%
-2.88%
1.86%
13.25%
16.8%
22.54%
Gross Profit Margin
17.85%
10.24%
-1.68%
10.22%
21.51%
26.39%
50.34%
PAT Margin
7.74%
1.4%
-8.15%
1.5%
14.68%
21.31%
42.15%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 22.52% vs 11.01% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 29,433.33% vs 100.36% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 20.81% vs 138.73% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -31.45% vs 9.76% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Beijing Beilu Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,197.39
0
1,197.39
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,197.39
0
1,197.39
Raw Material Cost
683.90
0
683.90
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
178.57
0
178.57
Power Cost
0
0
0.00
Manufacturing Expenses
40.15
0
40.15
Selling and Distribution Expenses
334.15
0
334.15
Other Expenses
-13.18
0.00
-13.18
Total Expenditure (Excl Depreciation)
1,104.93
0
1,104.93
Operating Profit (PBDIT) excl Other Income
92.46
0.00
92.46
Other Income
18.65
0
18.65
Operating Profit (PBDIT)
200.39
0
200.39
Interest
40.15
0
40.15
Exceptional Items
53.46
0
53.46
Gross Profit (PBDT)
513.49
0
513.49
Depreciation
102.65
0
102.65
Profit Before Tax
111.05
0
111.05
Tax
19.87
0
19.87
Provisions and contingencies
0
0
0.00
Profit After Tax
92.73
0
92.73
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
92.73
0
92.73
Share in Profit of Associates
0
0
0.00
Minority Interest
-4.09
0
-4.09
Other related items
0.00
0.00
0.00
Consolidated Net Profit
88.65
0
88.65
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,258.72
0
2,258.72
Earnings per share (EPS)
0.18
0
0.18
Diluted Earnings per share
0.18
0
0.18
Operating Profit Margin (Excl OI)
6.60%
0%
0.00
6.60%
Gross Profit Margin
17.85%
0%
0.00
17.85%
PAT Margin
7.74%
0%
0.00
7.74%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 119.74 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 22.52% vs 11.01% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 8.86 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 29,433.33% vs 100.36% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.17 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 20.81% vs 138.73% in Dec 2024

Annual - Interest
Interest 4.01 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -31.45% vs 9.76% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.60%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024